Signal detection for vaccine side effects that have not been specified in advance

An information‐theoretic definition of similarity proposed by Dekang Lin in 1998 appears to have attractive properties for identifying medically similar cases in a large database. Examination of similar cases that appear following vaccination may provide a way of detecting previously unexpected associations. A key element here is the inclusion of shared time‐since‐vaccination as a dimension of similarity while considering concordance on many other features. The system is potentially much more sensitive to patterns with multiple features than are very large, high‐dimension contingency tables. Copyright © 2009 John Wiley & Sons, Ltd.

[1]  J. Avorn,et al.  High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.

[2]  William DuMouchel,et al.  Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .

[3]  George Hripcsak,et al.  Mining a clinical data warehouse to discover disease-finding associations using co-occurrence statistics , 2005, AMIA.

[4]  Carolyn C Cannuscio,et al.  Cardiovascular risk of selective cyclooxygenase‐2 inhibitors and other non‐aspirin non‐steroidal anti‐inflammatory medications , 2006, Pharmacoepidemiology and drug safety.

[5]  C Michael Stein,et al.  COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease , 2002, The Lancet.

[6]  M. Kulldorff,et al.  A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance , 2011 .

[7]  R. Thompson,et al.  Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. , 1987, American journal of public health.

[8]  Richard Platt,et al.  Active Influenza Vaccine Safety Surveillance: Potential Within a Healthcare Claims Environment , 2009, Medical care.

[9]  A. M. Walker Pattern recognition in health insurance claims databases , 2001, Pharmacoepidemiology and drug safety.

[10]  George Hripcsak,et al.  A statistical methodology for analyzing co-occurrence data from a large sample , 2007, J. Biomed. Informatics.

[11]  C. Meschievitz,et al.  Efficacy of a two-component acellular pertussis vaccine in infants. , 1997, The Pediatric infectious disease journal.

[12]  A. Buist,et al.  Asthma drug use and the development of Churg–Strauss syndrome (CSS) , 2007, Pharmacoepidemiology and drug safety.

[13]  R. O’Neill,et al.  Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database , 2002, Drug safety.

[14]  A. M. Walker,et al.  Precautions for proactive surveillance , 2002, Pharmacoepidemiology and drug safety.

[15]  M. Kulldorff,et al.  Early detection of adverse drug events within population‐based health networks: application of sequential testing methods , 2007, Pharmacoepidemiology and drug safety.

[16]  S. Shoor,et al.  Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study , 2005, The Lancet.

[17]  Robert L Davis,et al.  Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events , 2007, Medical care.

[18]  Richard Beasley,et al.  Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. , 2004, Clinical therapeutics.

[19]  George Hripcsak,et al.  Use abstracted patient-specific features to assist an information-theoretic measurement to assess similarity between medical cases , 2008, J. Biomed. Informatics.

[20]  P. Diaconis,et al.  Testing for independence in a two-way table , 1985 .

[21]  David Madigan,et al.  Influence of the MedDRA® hierarchy on pharmacovigilance data mining results , 2009, Int. J. Medical Informatics.

[22]  M. Braun,et al.  Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. , 2001, Vaccine.